Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.19M | 6.22M | 3.34M | 1.82M | 1.36M | 1.06M |
Gross Profit | 3.85M | 4.59M | 2.33M | 669.57K | 514.32K | 439.97K |
EBITDA | -340.99K | 780.97K | 753.02K | 337.91K | 314.81K | 10.77K |
Net Income | -1.30M | -158.33K | 381.68K | 79.76K | 200.60K | -161.40K |
Balance Sheet | ||||||
Total Assets | 4.76M | 5.50M | 2.36M | 1.41M | 1.22M | 587.40K |
Cash, Cash Equivalents and Short-Term Investments | 462.81K | 533.85K | 841.35K | 294.13K | 65.11K | 25.29K |
Total Debt | 1.55M | 1.62M | 1.21M | 1.94M | 2.15M | 1.94M |
Total Liabilities | 2.59M | 3.19M | 2.21M | 2.70M | 2.58M | 2.24M |
Stockholders Equity | 2.17M | 2.32M | 145.97K | -1.29M | -1.36M | -1.66M |
Cash Flow | ||||||
Free Cash Flow | 1.16M | 797.00K | 89.98K | 604.26K | 45.29K | 33.20K |
Operating Cash Flow | 3.28M | 2.92M | 104.28K | 717.01K | 54.97K | 33.20K |
Investing Cash Flow | -2.10M | -2.11M | -14.30K | -112.75K | ― | 0.00 |
Financing Cash Flow | -1.20M | -1.12M | 535.33K | -387.83K | ― | -62.52K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | C$107.48M | ― | -72.52% | ― | -9.37% | 22.80% | |
61 Neutral | $10.29B | 6.41 | 0.55% | 2.90% | 3.32% | -39.60% | |
52 Neutral | C$507.02M | ― | -96.25% | ― | 203.80% | 16.89% | |
49 Neutral | C$14.78M | 86.54 | -86.10% | ― | 16.38% | -202.03% | |
45 Neutral | C$424.07K | 100.00 | ― | 109.13% | ― | ||
― | C$540.14K | ― | ― | ― | ― | ||
45 Neutral | C$111.50M | ― | -40.55% | ― | ― | 68.75% |
California Nanotechnologies Corp. reported a significant decrease in quarterly revenue, primarily due to reduced activity from its green steel customer and a slowdown in equipment deliveries. Despite a net loss and lower revenues, the company achieved a 156% year-over-year increase in manufacturing revenues from other customers, reflecting its efforts to diversify its customer base and secure longer-term contracts. The company is optimistic about future growth, supported by new commercial production orders and ongoing discussions with customers across various sectors.
California Nanotechnologies reported a record annual revenue of US$6.224 million for FY2025, marking an 87% increase year-over-year, driven by manufacturing services and SPS equipment sales. Despite a net loss due to non-cash charges from share purchase warrants, the company is strategically investing in its Santa Ana facility to enhance manufacturing capabilities and secure recurring commercial orders, positioning itself for sustainable long-term growth.